Renal Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Renal Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-19Clinical Trial Update: Symptomatic and Incidental RCC Detection
Completed clinical trial update focusing on symptomatic and incidental detection of renal cell carcinoma.
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: Ketogenic Dietary Intervention to Improve Response to Immunotherapy in Patients With Metastatic Melanoma and Metastatic Kidney Cancer [NA]
This clinical trial update notes a study evaluating whether a ketogenic diet can improve response to immunotherapy in patients with metastat…
-
EMA approval · 2026-03-18EMA Authorised: Opdivo (nivolumab) — Bristol-Myers Squibb Pharma EEIG
EMA authorised Opdivo (nivolumab) for multiple cancer indications, including melanoma, Hodgkin lymphoma, renal cell carcinoma, non-small cel…
-
CLINICAL_TRIALS trial_result · 2026-03-18Clinical Trial Update: Plinabulin in Combination With Radiation/Immunotherapy in Patients With Select Advanced Cancers After Progression on PD-1 or PD-L1 Targeted Antibodies [Phase 1, Phase 2]
Phase 1/2 trial of plinabulin with radiation and immunotherapy in select advanced cancers after progression on PD-1/PD-L1 therapy was termin…
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: Neoadjuvant of Axitinib Plus PD-1 to Improve Disease Free Survival of Patients With Renal Cell Carcinoma [Phase 3]
A Phase 3 neoadjuvant trial is evaluating axitinib plus a PD-1 inhibitor to improve disease-free survival in patients with renal cell carcin…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: 64Cu-GRIP B in Patients With Advanced Malignancies [Phase 1, Phase 2]
Clinical trial update for a Phase 1/Phase 2 study of 64Cu-GRIP B in advanced malignancies, including prostate and renal cancers, which is cu…
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: Targeted Decision Making In Renal Cell Carcinoma Relying on a Radiogenomics Translational Platform
A clinical trial investigating radiogenomics-based decision making for renal cell carcinoma, currently recruiting under IRCCS San Raffaele.
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: Phase Ib/II Clinical Study of SHR-8068 Combined With Adebrelimab and Other Anti-tumor Drugs in the Treatment of Advanced Renal Cell Carcinom [Phase 1, Phase 2]
Phase Ib/II clinical study evaluating SHR-8068 in combination with Adebrelimab for advanced renal cell carcinoma is currently recruiting. Th…
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: Radiofrequency Ablation Multicenter Observational Study in Renal Oncology Patients
A multicenter observational study evaluating radiofrequency ablation in patients with renal cell carcinoma. The sponsor is Humanitas Hospita…
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: Identification of Risk Factors Associated With Neoplastic Complications After Renal Transplantation in Nord-Pas de Calais , Normandy and Picardy Regions
A clinical trial update identifies factors associated with neoplastic complications in kidney transplant recipients in the Nord-Pas de Calai…
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: Transplantation of Reconstructed Renal Allografts Following Ex-Vivo Partial Nephrectomy [NA]
This clinical trial update describes a recruiting study by Case Comprehensive Cancer Center investigating transplantation of reconstructed r…
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: A Randomized Phase 2 Trial of Nivolumab, Relatlimab Plus Ipilimumab vs. Nivolumab Plus Ipilimumab in First-line Advanced Renal Cell Carcinoma (RCC) [Phase 2]
A randomized Phase 2 trial in first-line advanced renal cell carcinoma compares nivolumab with ipilimumab plus relatlimab versus nivolumab w…
-
CLINICAL_TRIALS withdrawal · 2026-03-13Clinical Trial Update: A Novel Haemostatic Agent for Robotic Partial Nephrectomy [NA]
A clinical trial evaluating a novel haemostatic agent for robotic partial nephrectomy has been withdrawn from ClinicalTrials.gov.
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: Study of Zanzalintinib in Combination With Immuno-Oncology Agents in Participants With Solid Tumors [Phase 1]
A Phase 1 study evaluating Zanzalintinib in combination with immuno-oncology agents in patients with various solid tumors; recruitment is on…
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform
This clinical trial update describes the use of a live tumor diagnostic platform to evaluate immune checkpoint inhibitor responses across mu…
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: Open-Label Phase 1/2 Study of NEO-811 in Subjects With Locally Advanced or Metastatic Non-Resectable Clear Cell Renal Cell Carcinoma [Phase 1]
Announces an open-label Phase 1/2 study of NEO-811 for locally advanced or metastatic non-resectable clear cell renal cell carcinoma, curren…
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: 68Ga-PSMA PET in the Renal Cell Carcinoma [NA]
A clinical trial is evaluating 68Ga-PSMA PET imaging for renal cell carcinoma with metastases and is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: Laparoscopic Versus Open Nephrectomy : Clinical Effectivness and Cost Analysis [NA]
An active recruiting study comparing laparoscopic versus open nephrectomy in patients with nonfunctioning kidney and renal cell carcinoma, e…
-
CLINICAL_TRIALS research · 2026-03-09Clinical Trial Update: Frequency and Clinical Phenotype of BAP1 Hereditary Predisposition Syndrome
An ongoing clinical trial is recruiting to study the frequency and clinical phenotype of BAP1 tumor predisposition syndrome and its associat…
-
CLINICAL_TRIALS trial_result · 2026-03-06Clinical Trial Update: Study of Adaptive Immunotherapy With VEGFR-TKI in Patients With Advanced RCC [Phase 2]
A Phase 2 study evaluating adaptive immunotherapy with a VEGFR-TKI in patients with advanced renal cell carcinoma has been suspended.
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: Yttrium-90 (Y90) Radioembolization for the Treatment of Early Stage Renal Cell Carcinoma, The RENEGADE Trial [Phase 1, Phase 2]
Ongoing Phase 1/2 study (RENEGADE) evaluating Yttrium-90 radioembolization for early-stage renal cell carcinoma, currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-03-05Clinical Trial Update: Perioperative TORIPALIMAB Plus LENVATINIB in Patients With Renal Cell Carcinoma Undergoing Nephrectomy (PLUTO) [Phase 2]
The Phase 2 PLUTO trial evaluating perioperative toripalimab plus lenvatinib in renal cell carcinoma patients undergoing nephrectomy has bee…
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: Lenvatinib With Everolimus Versus Cabozantinib for Second-Line or Third-Line Treatment of Metastatic Renal Cell Cancer [Phase 2]
This Phase 2 clinical trial compares lenvatinib plus everolimus versus cabozantinib for second- or third-line treatment of metastatic clear …
-
CLINICAL_TRIALS trial_result · 2026-03-05Clinical Trial Update: A Study of Belzutifan (MK-6482) in Combination With Lenvatinib Versus Cabozantinib for Treatment of Renal Cell Carcinoma (MK-6482-011) [Phase 3]
A Phase 3 trial (MK-6482-011) compares belzutifan in combination with lenvatinib versus cabozantinib for renal cell carcinoma; the study is …
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: CBM588 in Combination With Nivolumab and Cabozantinib for the Treatment of Advanced or Metastatic Kidney Cancer [Phase 1]
Phase 1 trial evaluating CBM588 in combination with nivolumab and cabozantinib for advanced or metastatic renal cell carcinoma.